Early this afternoon, Opes Acquisition Corp. (OPES), released the details of their shareholder vote to approve their extension deadline from January 15, 2020 to February 15, 2020, or March 15, 2020, if they need to extend an additional 30 days further. And the results were pretty good. In fact, only 18,133 shareholders opted to redeem, or less than 1% of it’s shareholders heading into the vote.
RESULTS
Per the 8-K, 18,133 of the Company’s common stock elected to redeem at a price of $10.52 share, which resulted in only $190,800 being removed from the Trust Account. Furthermore, approximately 8,971,113 public shares will remain issued and outstanding, which means that the Trust Account is now currently estimated to hold $94.4 million, down from their estimated $94.6 million held in trust before the vote.
Additionally, the Company’s Sponsor will be contributing $291,561 to the trust, or $0.0325 for each public share that was not converted in connection with the Extension for each 30-day extension, or $0.065 for both months.
This was a great extension vote result, so let’s see if Opes can keep it moving and follow it up with a winning announced deal.
You can review the results of the vote HERE.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...